Heron Neutron Medical Corp.

Research Heron Neutron Medical Corp. (7799.TW) on Bullrun: market cap TWD 71.68B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 71.68B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 71.68Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Heron Neutron Medical Corp.

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.

ETFs that hold Heron Neutron Medical Corp.

US-listed ETFs

Heron Neutron Medical Corp. is held by 6 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:

ETFWeightFee
iShares Core MSCI Emerging Markets ETF (IEMG)<0.01%0.09%
Vanguard Total International Stock Index Fund ETF Shares (VXUS)<0.01%0.05%
Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO)<0.01%0.06%
Vanguard Total World Stock Index Fund ETF Shares (VT)<0.01%0.06%
iShares Core MSCI Total International Stock ETF (IXUS)<0.01%0.07%
Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS)0.01%0.06%

Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Heron Neutron Medical Corp.'s market cap?

Heron Neutron Medical Corp.'s market capitalization is TWD 71.68B.

What does Heron Neutron Medical Corp. do?

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.